Literature DB >> 20664939

Molecular characterization of tumors from a transgenic mouse adrenal tumor model: comparison with human pheochromocytoma.

Yoshiyuki Hattori1, Naotetsu Kanamoto, Kumi Kawano, Hiroshi Iwakura, Masakatsu Sone, Masako Miura, Akihiro Yasoda, Naohisa Tamura, Hiroshi Arai, Takashi Akamizu, Kazuwa Nakao, Yoshie Maitani.   

Abstract

Adrenal neuroblastoma and pheochromocytoma have the same embryonic origin from neural crest cells and mainly arise from the adrenal medulla. Recently, transgenic mice exhibiting tumors in the bilateral adrenal medulla by the expression of SV40 T-antigen were developed. In this study, we investigated mRNA expression in adrenal tumors of transgenic mice and compared them with human pheochromocytoma by DNA microarray analysis. To compare mouse adrenal tumors and human pheochromacytoma, we found that the expressions of noradrenergic neuron-related genes, including dopa decarboxylase, phenylethanolamine-N-methyltransferase and chromogranin B, were up-regulated in humans but not in mice; however, the expression of neuroblastoma-related genes, including Mycn, paired-like homeobox 2b, gamma-aminobutyric acid A receptor beta3 subunit, islet 1 and kinesin family member 1A, was up-regulated in both species. From the gene expression profiles, the characterization of mouse adrenal tumor, may be similar to that of human adrenal neuroblastoma rather than pheochromacytomas. This mouse model would be a useful tool for the development of anti-cancer drugs and for understanding the etiology of adrenal neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664939     DOI: 10.3892/ijo_00000719

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

Review 1.  Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.

Authors:  Louis Chesler; William A Weiss
Journal:  Semin Cancer Biol       Date:  2011-09-21       Impact factor: 15.707

2.  Adrenal tumor volume in a genetically engineered mouse model of neuroblastoma determined by magnetic resonance imaging.

Authors:  Kumi Kawano; Yoshiyuki Hattori; Hiroshi Iwakura; Takashi Akamizu; Yoshie Maitani
Journal:  Exp Ther Med       Date:  2012-05-02       Impact factor: 2.447

3.  Role of endogenous insulin gene enhancer protein ISL-1 in angiogenesis.

Authors:  Si-Qi Xiong; Hai-Bo Jiang; Yan-Xiu Li; Hai-Bo Li; Hui-Zhuo Xu; Zhen-Kai Wu; Wei Zheng; Xiao-Bo Xia
Journal:  Mol Vis       Date:  2016-12-02       Impact factor: 2.367

4.  ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis.

Authors:  Lin Li; Fuwen Sun; Xiaoyan Chen; Minghui Zhang
Journal:  Onco Targets Ther       Date:  2018-02-14       Impact factor: 4.147

5.  Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma.

Authors:  Kumi Kawano; Yoshiyuki Hattori; Hiroshi Iwakura; Takashi Akamizu; Yoshie Maitani
Journal:  Cancer Med       Date:  2013-04-02       Impact factor: 4.452

Review 6.  Zebrafish as a Neuroblastoma Model: Progress Made, Promise for the Future.

Authors:  Shuai Li; Kok Siong Yeo; Taylor M Levee; Cassie J Howe; Zuag Paj Her; Shizhen Zhu
Journal:  Cells       Date:  2021-03-06       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.